The 5-lipoxygenase (5-LO) cascade and atherosclerosis in mice and men

被引:0
|
作者
Loetzer, K [1 ]
Graebner, R [1 ]
Kaiser, B [1 ]
John, N [1 ]
Moos, M [1 ]
Spanbroek, R [1 ]
Hildner, M [1 ]
Funke, H [1 ]
Habenicht, AJR [1 ]
机构
[1] Univ Jena, Sch Med, Inst Vasc Med, D-07743 Jena, Germany
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:21 / 22
页数:2
相关论文
共 50 条
  • [1] Genes in the 5-lipoxygenase (5-LO) pathway : association with COPD
    Sims, A. -M.
    Damholt, A.
    Knutsson, M.
    Carlholm, M.
    Carlsson, L. -G.
    Lofdahl, C. -G.
    Postma, D.
    Semb, K. F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [2] 5-lipoxygenase (5-LO) is involved in Kupffer cell survival
    Titos, E
    Claria, J
    Planaguma, A
    Lopez-Parra, M
    Villamor, N
    Jimenez, W
    Arroyo, V
    Rivera, F
    Rodés, J
    JOURNAL OF HEPATOLOGY, 2002, 36 : 75 - 75
  • [3] Induction of hepatic microsomal drug-metabolizing enzymes by inhibitors of 5-lipoxygenase (5-LO): Studies in rats and 5-LO knockout mice
    Beierschmitt, WP
    McNeish, JD
    Griffiths, RJ
    Nagahisa, A
    Nakane, M
    Amacher, DE
    TOXICOLOGICAL SCIENCES, 2001, 63 (01) : 15 - 21
  • [4] THE EFFECTS OF 5-LIPOXYGENASE (5-LO) INHIBITORS IN A MODEL OF ENDOTOXEMIA IN THE RAT
    YOUNG, PR
    RACH, W
    BARLOW, J
    SONSALLA, J
    ALBERT, DH
    SUMMERS, JB
    BROOKS, DW
    CARTER, GW
    FASEB JOURNAL, 1988, 2 (05): : A1264 - A1264
  • [5] Synthesis and profiling of CNS prodrugs of 5-lipoxygenase (5-LO) inhibitors
    Fan, Rong
    Gordon, John
    Blass, Benjamin
    Abou-Gharbia, Magid
    Childers, Wayne
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [6] Interdependent roles of nitric oxide (NO) and 5-lipoxygenase (5-LO) during accelerated nephrotoxic serum nephritis (aNTS) in 5-LO gene deleted mice (5-LO-/-).
    Munger, KA
    Cruet, E
    Fogo, A
    Funk, C
    Badr, KF
    FASEB JOURNAL, 1996, 10 (03): : 2165 - 2165
  • [7] 5-lipoxygenase (5-lo) is involved in kupffer cell survival. role of 5-lo products in the pathogenesis of liver fibrosis
    Titos, E
    Claria, J
    Planaguma, A
    Lopez-Parra, M
    Villamor, N
    Miquel, R
    Jimenez, W
    Rivera, F
    Arroyo, V
    Rodes, J
    HEPATOLOGY, 2002, 36 (04) : 256A - 256A
  • [8] A-63162, A POTENT ORALLY ACTIVE INHIBITOR OF 5-LIPOXYGENASE (5-LO)
    CARTER, GW
    YOUNG, PR
    DYER, R
    ALBERT, DH
    BOUSKA, J
    BARLOW, J
    ROBERTS, E
    SONSALLA, J
    SUMMERS, J
    BROOKS, D
    FASEB JOURNAL, 1988, 2 (05): : A1263 - A1263
  • [9] CHARACTERIZATION OF CGS-8515 AS A SELECTIVE 5-LIPOXYGENASE (5-LO) INHIBITOR
    KU, EC
    RAYCHAUDHURI, A
    GHAI, G
    KIMBLE, EF
    LEE, WH
    COLOMBO, C
    DOTSON, R
    WHITE, D
    OGLESBY, TD
    WASLEY, JWF
    ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1989, 19 : 86 - 89
  • [10] Characterization and cellular localization of human 5-lipoxygenase and its protein isoforms 5-LOΔ13, 5-LOΔ4 and 5-LOp12
    Ball, Ann-Katrin
    Beilstein, Kim
    Wittmann, Sandra
    Sueruen, Duran
    Saul, Meike J.
    Schnuetgen, Frank
    Flamand, Nicolas
    Capelo, Ricardo
    Kahnt, Astrid S.
    Frey, Helena
    Schaefer, Liliana
    Marschalek, Rolf
    Haefner, Ann-Kathrin
    Steinhilber, Dieter
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2017, 1862 (05): : 561 - 571